New York Is Using Race to Determine Access to Covid Treatments
greenwald.substack.com
New York Is Using Race to Determine Access to Covid Treatments
1–10 of 29 posts
Re: New York Is Using Race to Determine Access to Covid Treatments
#2Re: New York Is Using Race to Determine Access to Covid Treatments
#3Re: New York Is Using Race to Determine Access to Covid Treatments
#4This has to be satire.
http://www.mssnyenews.org/wp-content/uploads/2021/12/122821_...
The statement about race is the last bullet point on page 2.
Re: New York Is Using Race to Determine Access to Covid Treatments
#5They are using race to preferentially treat higher risk groups of people.
Sounds like the way you should treat people - higher risk first. Very click bait title.
Re: New York Is Using Race to Determine Access to Covid Treatments
#6https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investi... They are using race to preferentially treat higher risk groups of people. Sounds like the way you should treat people - higher risk first. Very click bait title.
Re: New York Is Using Race to Determine Access to Covid Treatments
#7Re: New York Is Using Race to Determine Access to Covid Treatments
#8Quoted post unavailable.
> Race is a statistical risk factor for covid because it correlates with numerous conditions like lower vaccination rates, higher obesity in some groups, worse medical care and so on.
This is plainly stated in the article. As is the fact that people with medical conditions (like obesity, or things that are the result of poor medical care) are already prioritized. Vaccination status is not.
His hypothesis seems to be that prioritizing non-white people is an attempt to prioritize unvaccinated people (seeing as the other risk factors are already being accounted for). He is claiming that it is more acceptable to exclude white people from the treatment than it is to say that you are giving preference to people who are unvaccinated.
Re: New York Is Using Race to Determine Access to Covid Treatments
#9With the Omicron variant now the dominant strain, the evidence is that there are no effective antiviral monoclonal treatments; there are two that seem to be exceptions, but neither one is available or even in trials in the US.